NuScale Power is in a sustained downtrend, with the stock price declining 74.9% over the past year. The current price of $9.04 sits at just 15.7% of its 52-week range (low $8.55, high $57.42), indicating the stock is near its lows and deeply oversold. This positioning suggests a potential value opportunity if fundamentals improve, but also reflects a falling knife scenario with significant downside risk. The 1-year relative strength versus SPY is -95.5%, confirming extreme underperformance. Short-term momentum shows a 1-month price change of -2.7% and a 3-month change of -1.8%, indicating a deceleration in the rate of decline compared to the 6-month change of -55.9%. This divergence could signal a potential bottoming process or a temporary pause before further downside. The beta of 2.252 implies the stock is 125% more volatile than the market, amplifying both upside and downside moves. Key support lies at the 52-week low of $8.55; a breakdown below this level would signal further weakness and potentially accelerate selling. Resistance is at the 52-week high of $57.42, a breakout above which would indicate a major trend reversal, though unlikely given current fundamentals.

NuScale's revenue trajectory is highly erratic and declining, with Q4 2025 revenue of $1.808 million representing a 94.7% year-over-year decline from $34.224 million in Q4 2024. The company has no recurring revenue streams, and its revenue is tied to sporadic project milestones. The multi-quarter trend shows revenue falling from $13.375 million in Q1 2025 to $1.808 million in Q4 2025, indicating a decelerating and unsustainable growth profile. The company remains deeply unprofitable, with a net loss of $50.829 million in Q4 2025 and a gross margin of -3.4% (negative gross profit of $60,999). Operating margin worsened to -40.2% in Q4 2025 from -2.6% in Q1 2025, reflecting escalating costs relative to revenue. The net margin of -28.1% shows that losses are consuming a significant portion of revenue, and there is no clear path to profitability in the near term. NuScale has zero debt (debt-to-equity ratio of 0) and a current ratio of 4.3, indicating strong liquidity. However, free cash flow is deeply negative at -$204.1 million in Q4 2025, and the company relies heavily on equity financing (common stock issued of $737.9 million in Q4 2025) to fund operations. ROE is -30.4%, reflecting poor returns on shareholder equity. The company's cash burn rate is high, and without sustained capital markets access, it faces funding risk.